Defoslimod

N/A

Report date: 2024/06/27 20:00:09
NME

Base Information

Drug NameDefoslimod
Drug Alias Namedefoslimodum地磷莫德OM-174OM-174-DP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 4 modulators
TargetsToll like receptor 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOm Pharma SaCentre Hospitalier Universitaire Dijon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentre Hospitalier Universitaire Dijon
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A